Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Mbula Mambimbi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of General Medicine|December 11, 2012
Nadir CD4+, religion, antiretroviral therapy, incidence of type 2 diabetes mellitus, and increasing rates of obesity among black Africans with HIV diseaseMadone Mandina Ndona, Benjamin Longo-Mbenza, Roger Wumba, et al.
Plos One|November 5, 2021
Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017Nadine Mayasi Ngongo, Gilles Darcis, Hippolyte Situakibanza Nanituna, et al.
AIDS Research and Therapy|July 17, 2021
Decrease in late presentation for HIV care in Kinshasa, DRC, 2006-2020Nadine Mayasi Ngongo, Hippolyte Situakibanza Nani-Tuma, Marcel Mbula Mambimbi, et al.
Cardiovascular Journal of Africa|May 6, 2015
Association of Helicobacter pylori infection with the metabolic syndrome among HIV-infected black Africans receiving highly active antiretroviral therapyBenjamin Longo-Mbenza, Teke Apalata, Murielle Longokolo, et al.
Plos One|May 19, 2022
Clinical epidemiology and high genetic diversity amongst Cryptococcus spp. isolates infecting people living with HIV in Kinshasa, Democratic Republic of CongoBive Zono Bive, Rosalie Sacheli, Hippolyte Situakibanza Nani-Tuma, et al.
Open Forum Infectious Diseases|June 26, 2023
Human Immunodeficiency Virus Viral Load Monitoring and Rate of Virologic Suppression Among Patients Receiving Antiretroviral Therapy in Democratic Republic of the Congo, 2013-2020Nadine Mayasi Ngongo, Erick Kamangu Ntambwe, Hippolyte Situakibanza Nani-Tuma, et al.
The Pan African Medical Journal|August 28, 2023
[Interventional study on Dolutegravir and other antiretrovirals in patients with subclinical atherosclerosis in the Kinshasa Hospital]Murielle Longokolo Mashi, Marcel Mbula Mambimbi, Hippolyte Nani-Tuma Situakibanza, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of General Medicine|December 11, 2012
Nadir CD4+, religion, antiretroviral therapy, incidence of type 2 diabetes mellitus, and increasing rates of obesity among black Africans with HIV diseaseMadone Mandina Ndona, Benjamin Longo-Mbenza, Roger Wumba, et al.
Plos One|November 5, 2021
Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017Nadine Mayasi Ngongo, Gilles Darcis, Hippolyte Situakibanza Nanituna, et al.
AIDS Research and Therapy|July 17, 2021
Decrease in late presentation for HIV care in Kinshasa, DRC, 2006-2020Nadine Mayasi Ngongo, Hippolyte Situakibanza Nani-Tuma, Marcel Mbula Mambimbi, et al.
Cardiovascular Journal of Africa|May 6, 2015
Association of Helicobacter pylori infection with the metabolic syndrome among HIV-infected black Africans receiving highly active antiretroviral therapyBenjamin Longo-Mbenza, Teke Apalata, Murielle Longokolo, et al.
Plos One|May 19, 2022
Clinical epidemiology and high genetic diversity amongst Cryptococcus spp. isolates infecting people living with HIV in Kinshasa, Democratic Republic of CongoBive Zono Bive, Rosalie Sacheli, Hippolyte Situakibanza Nani-Tuma, et al.
Open Forum Infectious Diseases|June 26, 2023
Human Immunodeficiency Virus Viral Load Monitoring and Rate of Virologic Suppression Among Patients Receiving Antiretroviral Therapy in Democratic Republic of the Congo, 2013-2020Nadine Mayasi Ngongo, Erick Kamangu Ntambwe, Hippolyte Situakibanza Nani-Tuma, et al.
The Pan African Medical Journal|August 28, 2023
[Interventional study on Dolutegravir and other antiretrovirals in patients with subclinical atherosclerosis in the Kinshasa Hospital]Murielle Longokolo Mashi, Marcel Mbula Mambimbi, Hippolyte Nani-Tuma Situakibanza, et al.
Pageof 1